Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 516859, 4 pages
http://dx.doi.org/10.1155/2014/516859
Research Article

Seropositivity and Coinfection of Hepatitis B and C among Patients Seeking Hospital Care in Islamabad, Pakistan

1Department of Microbiology, Kohat University of Science and Technology, Kohat 26000, Khyber Pakhtunkhwa, Pakistan
2Department of Zoology, Kohat University of Science and Technology, Kohat 26000, Pakistan
3Department of Chemistry, Government College Ara Khel, FR Kohat 26000, Pakistan
4Riyadh Community College, King Saud University, Riyadh 11437, Saudi Arabia
5Department of Chemistry, Sarhad University of Science and Information Technology, Peshawar 25000, Pakistan

Received 22 February 2014; Revised 19 May 2014; Accepted 28 May 2014; Published 24 June 2014

Academic Editor: Giulia Morsica

Copyright © 2014 Jafar Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Elizabeth, “Global epidemiology of hepatitis B virus, (HBV) infection,” North American Journal of Medical Sciences, vol. 4, pp. 7–13, 2011. View at Google Scholar
  2. M. H. Khayriyyah, J. Groeger, A. D. Flaxman, and S. T. Wiersma, “Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence,” Hepatology, vol. 57, no. 4, pp. 1333–1342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Stephane and P. Jean-Michael, “Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes,” Best Practice and Research: Clinical Gastroenterology, vol. 22, no. 6, pp. 1031–1048, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. I. T. Williams, J. F. Perz, and B. P. Bell, “Viral hepatitis transmission in ambulatory health care settings,” Clinical Infectious Diseases, vol. 38, no. 11, pp. 1592–1598, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. World Health Organization, “Hepatitis B vaccines,” Weekly Epidemiological Record, vol. 40, pp. 405–420, 2009. View at Google Scholar
  6. H. Qureshi, K. M. Bile, R. Jooma, S. E. Alam, and H. U. R. Afridi, “Prevalence of hepatitis B and C viral infections in pakistan: findings of a national survey appealing for effective prevention and control measures,” Eastern Mediterranean Health Journal, vol. 16, pp. 15–23, 2010. View at Google Scholar · View at Scopus
  7. S. Jamma, G. Hussain, and D. T.-Y. Lau, “Current concepts of HBV/HCV coinfection: coexistence, but not necessarily in harmony,” Current Hepatitis Reports, vol. 9, no. 4, pp. 260–269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-L. Fong, A. M. di Bisceglie, J. G. Waggoner, S. M. Banks, and J. H. Hoofnagle, “The significance of antibody to hepatitis C virus in patients with chronic hepatitis B,” Hepatology, vol. 14, no. 1, pp. 64–67, 1991. View at Google Scholar · View at Scopus
  9. A. S. Mohamed, M. A. Alkarawi, and G. A. Mesa, “Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients,” Hepato-Gastroenterology, vol. 44, no. 17, pp. 1404–1406, 1997. View at Google Scholar · View at Scopus
  10. E. Villa, A. Grottola, P. Buttafoco et al., “High doses of α-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial,” American Journal of Gastroenterology, vol. 96, no. 10, pp. 2973–2977, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Muhammad, N. Muhammad, and N. Uzma, “Sero-prevalence of HCV and associated infections with HIV and HBV among prisoners in Lahore,” Biomedica, vol. 27, pp. 119–122, 2011. View at Google Scholar
  12. A. Raja, K. Waheed, A. Waqaruddin, E. A. Syed, and A. Ambreen, “Screening of HBsAg and anti HCV from tertiary care, private and public sector hospitals,” Pakistan Journal of Medical Research, vol. 50, pp. 20–23, 2011. View at Google Scholar
  13. A. Gull, N. Jamal, and H. Abbas, “Seropositivity of HbsAg and Anti HCV in Rawalpindi and Islamabad and analysis of risk factors,” Annals of Pakistan Institute of Medical Sciences, vol. 5, pp. 242–244, 2009. View at Google Scholar
  14. G. R. Pennap, A. Yakubu, O. Oyige, and J. Forbi, “Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria,” African Journal of Microbiology Research, vol. 4, no. 4, pp. 274–278, 2010. View at Google Scholar · View at Scopus
  15. A. Al-Ajlan, “Prevalence of hepatitis B and C among students of health colleges in Saudi Arabia,” Eastern Mediterranean Health Journal, vol. 17, no. 10, pp. 759–762, 2011. View at Google Scholar · View at Scopus
  16. R. K. Obi, S. S. Umeh, O. H. Okurede, and L. L. Iroagba, “Prevalence of hepatitis B virus infection among pregnant women in antenatal clinic in PortHarcourt, Nigeria,” African Journal of Clinical and Experimental Microbiology, vol. 7, pp. 78–82, 2006. View at Google Scholar
  17. R. H. Raja, K. Ghazala, Q. Mazhar, A. Muhammad, and K. Azra, “Association of diabetes with hepatitis C. virus, (HCV) infected male and female patients along with different risk factors,” International Journal of Agriculture and Biology, vol. 5, pp. 736–740, 2007. View at Google Scholar